mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.2 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.3 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.3 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.3 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.32 |
0.3 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |